Catalyst Wire Dossier Catalyst Wire Dossier

Allo-CAR-T cells

allogeneic CAR-T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allo-CAR-T cells, covering 2018-03-13 to 2018-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia [Phase 1]

See pricing